GBA1 and Parkinson disease: Lysosomal biomarkers: Studies have shown that dysfunction in the lysosomal pathway, particularly through biomarkers like glucocerebrosidase, can be associated with PD and may help in distinguishing PD from other neurodegenerative disorders.